✦ LIBER ✦

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

✍ Scribed by Clive Holmes; Delphine Boche; David Wilkinson; Ghasem Yadegarfar; Vivienne Hopkins; Anthony Bayer; Roy W Jones; Roger Bullock; Seth Love; James W Neal; Elina Zotova; James AR Nicoll

Book ID: 117303300
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 283 KB
Volume: 372
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(08)61075-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The dementia antipsychotic withdrawal tr

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial

✍ Clive Ballard; Maria Luisa Hanney; Megan Theodoulou; Simon Douglas; Rupert McSha 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

Long-term use of standardised ginkgo bil

Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

✍ Bruno Vellas; Nicola Coley; Pierre-Jean Ousset; Gilles Berrut; Jean-François Dar 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 210 KB

Does reducing the frequency of routine a

Does reducing the frequency of routine antenatal visits have long term effects? Follow up of participants in a randomised controlled trial

✍ Sarah Clement; Bridget Candy; Jim Sikorski; Jenny Wilson; Nigel Smeeton 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Long term follow up of a randomised tria

Long term follow up of a randomised trial comparing local radiotherapy with wide field radiotherapy in stage I and II Hodgkin's disease

✍ P. Hoskin; P. Smith; D. Linch 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 183 KB

P149 A PROSPECTIVE RANDOMISED CONTROLLED

P149 A PROSPECTIVE RANDOMISED CONTROLLED TRIAL OF NUTRITIONAL THERAPY IN COLORECTAL CANCER PATIENTS SUBMITTED TO RADIOTHERAPY: THE LONG TERM FOLLOW-UP

✍ P. Ravasco; I. Monteiro Grillo; M. Camilo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Safety, efficacy, and biomarker findings

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

✍ Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 194 KB